Annual Meeting 2024

Read the Late-Breaking Abstracts Ahead of #ASGCT2024

Preview them before the Annual Meeting - May 03, 2024

ASGCT's late-breaking abstracts will be presented from Wednesday, May 8 through Friday, May 10.

The American Society of Gene and Cell Therapy's (ASGCT) late-breaking abstracts are a highly anticipated and exciting showcase of the latest cutting-edge research that is high impact, groundbreaking, innovative, and newsworthy.

Preview these exhilarating presentations prior to the Annual Meeting by reading them here.

Read the late-breaking abstracts

Learn more at the meeting! Late-breaking abstracts will be presented:

Wednesday, May 8

  • 5:30 - 7 p.m.
    Poster reception (LBAs #15-25)
    Exhibit Hall

Thursday, May 9

  • 8 - 9:45 a.m.
    Oral session 1
    Ballroom 3

  • 5:30 - 7 p.m.
    Poster reception (LBAs #26-36)
    Exhibit Hall

Friday, May 10

There's still time to join us in Baltimore or virtually! Register here before rates increase May 6.

 

Related Articles

Dr. Chamberlain (far right) serves as session chair  with (from left) Gary Gibbons, MD, Joni Rutter, PhD, Amy Jenkins, PhD, and Amir Tamiz, PhD.

Annual Meeting 2024

Bridging the Gap: Why Translational Research is Key to Unlocking Cell & Gene Therapy Innovation

Jeffrey S. Chamberlain, PhD - July 22, 2024

Maria Santaella, PhD (c), MSN, RN-BC, CPHON serves as the Vice President of Research for the National Bleeding Disorders Foundation. During the workshop she spoke on clinical trial enrollment by sharing strategies to address barriers in recruiting.

Annual Meeting 2024

Inclusive Trial Design Amplifies Patient Voices and Drives Meaningful Outcomes

Samuel Hughes, MBA, St. Jude Children's Research Hospital - June 18, 2024
Annual Meeting 2024

Patient Advocates Connect at the Annual Meeting

Ali Kujawski, Senior Patient Outreach Manager - June 12, 2024
Annual Meeting 2024

Congratulations to These #ASGCT2024 Poster Presenters

View the full abstract collection - May 17, 2024